45689.1 IP-LS

Résumé

WIP: Novel GPCR screening method in microfluidic device for disease-related GPCRs.

Textes supplémentaires

Abstract

G Protein Coupled Receptors (GPCR) are the most successful drug targets to treat diseases like cancer, Parkinson#s or Alzheimer#s. Current assays to find new drugs being limited, we aim with this project to revolutionize GPCR drug screening with a new assay embedded in a microfluidic chip.

Participants

Thamani Dahoun

Kontaktperson

CHUV Centre hospitalier universitaire va Thamani Dahoun Avenue de Beaumont Pavillon 3 1011 Lausanne VD CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2020-09-30
Date de fin: 2022-03-31
Coûts totaux approuvés: CHF 357561.11
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T115 Medical technology 100.0%